Healing Through Writing: An Odyssey Through Acute Myeloid Leukemia (AML)

Steve Buechler

As a cancer patient or caregiver, telling your story can not only be a way to update loved ones about your condition or be a comfort to current patients, it can be healing for yourself. In this episode, we speak to Steve Buechler about his treatment for acute myeloid leukemia as well as his experience through survivorship.

Steve shares how writing helped him heal from the emotional effects of cancer. As an LLS volunteer, he now facilitates writing workshops for our LLS Community and wrote an article about how language matters when speaking to patients.

Join us to hear about Steve’s “odyssey” through AML, which he describes as not something he chose, but something that taught him more about life and himself.

CLICK HERE to participate in our episode survey.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this program is provided by: Bristol Myers Squibb.

4 Comments

  1. How do you tell if you have AML. My primary thinks yes. My oncologist says no. My cappa cells have reached 71.

  2. Thank you Dr. Bhatnagar!This podcast on tumorlysis was so helpful with great information. I only wish I knew about it before my husband had it happen to him, and how the doctors all glossed over it like it was unlikely to happen To learn that there are labs and markers to indicate he may have been more susceptible to it and they did not know or recognize or do anything to prevent him from going into tumorlysis. I’m so upset by this. Even as I asked the oncologists, PAs if it was tumorlysis and they kept telling me “no it wasn’t”. He went into kidney failure and put on dialysis (too late in my opinion based on what I’ve learned after the fact). So many questions about how to go forward and what next steps are in my husband’s treatment of CLL/SLL and how his kidney issues can impact him and future treatments which are imminent in next 6-12 months.

Leave a Comment

Your email address will not be published. Required fields are marked *